Yoshihiro Sakamoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yoshihiro Sakamoto has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Atsushi Toyonaga
Unit of Gastroenterology and GI Endoscopy Yasumoto Hospital Kurume Fukuoka Japan
1 shared publicationEisuke Tanaka
Department of Radiology (YT) and the Second Department of Medicine (RK, TA, YS, RT, KO, YK, TI, NO, ET, MS), Kurume University, School of Medicine, Kurume, Fukuoka, Japan; and Institute of Gastroenterology (KI, HA), Asakura Prefecture Hospital, Amagi, Fukuoka, Japan
1 shared publicationHirohiko Abe
Department of Radiology (YT) and the Second Department of Medicine (RK, TA, YS, RT, KO, YK, TI, NO, ET, MS), Kurume University, School of Medicine, Kurume, Fukuoka, Japan; and Institute of Gastroenterology (KI, HA), Asakura Prefecture Hospital, Amagi, Fukuoka, Japan
1 shared publicationHiroto Inoue
Division of Gastroenterology, Department of Medicine Kurume University School of Medicine Kurume Fukuoka Japan
1 shared publicationKazuhiko Oho
Division of Gastroenterology Yanagawa Hospital Yanagawa Fukuoka Japan
1 shared publication- Kei Ogata
Department of Gastroenterology, Kurume University Medical Center, Kurume 839-0863, Japan
1 shared publication
Latest Publications
- 12 April 2013
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 28 (9) , 1444-1449
Effect of Helicobacter pylori infection on esophagogastric variceal bleeding in patients with liver cirrhosis and portal hypertension
Background and Aims: Bleeding from esophageal and gastric varices is a fatal event in patients with liver cirrhosis and portal hypertension. However, the effects of Helicobacter pylori (H. pylori) infection on esophagogastric variceal bleeding are not known. The present study was aimed to elucidate the role of H. pylori infection in esophagogastric variceal bleeding.Methods: The subjects were 196 cirrhotic patients who were admitted to the Kurume University Hospital to treat their esophagogastric varices consisted of 95 with acute bleeding and 101 with nonbleeding but high risk of bleeding. For the diagnosis of H. pylori infection, a 13C‐urea breath test was used, and serum pepsinogen (PG) I and II levels and the PG I/II ratio were also measured.Results: Esophagogastric variceal bleeding was seen in 34.9% (n = 30) of the H. pylori‐infected patients (n = 86) and in 59.1% (n = 65) of the noninfected patients (n = 110) (P < 0.0007). There was no significant difference in the infection rate between the bleeding sites of the esophagus and the stomach. The serum PG I and II levels and the PG I/II ratio were 65.6 ng/dL, 14.7 ng/dL, and 4.4, respectively, for the bleeding patients (n = 95), and 43.7 ng/dL, 17.7 ng/dL, and 3.1 for the nonbleeding patients (n = 101). Thus, the nonbleeding patients had significantly higher rate of H. pylori infection and lower acid secretion than bleeding patients (0.001). In addition, multivariate logistic regression analysis showed a significant negative association between H. pylori infection and esophagogastric variceal bleeding.Conclusions: These results suggest that H. pylori infection has a protective effect against esophagogastric variceal bleeding through the induction of gastric mucosal atrophy and concomitant hypoacidity.
- 12 April 2013
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 28 (9) , 1444-1449
Effect of Helicobacter pylori infection on esophagogastric variceal bleeding in patients with liver cirrhosis and portal hypertension
Background and Aims: Bleeding from esophageal and gastric varices is a fatal event in patients with liver cirrhosis and portal hypertension. However, the effects of Helicobacter pylori (H. pylori) infection on esophagogastric variceal bleeding are not known. The present study was aimed to elucidate the role of H. pylori infection in esophagogastric variceal bleeding.Methods: The subjects were 196 cirrhotic patients who were admitted to the Kurume University Hospital to treat their esophagogastric varices consisted of 95 with acute bleeding and 101 with nonbleeding but high risk of bleeding. For the diagnosis of H. pylori infection, a 13C‐urea breath test was used, and serum pepsinogen (PG) I and II levels and the PG I/II ratio were also measured.Results: Esophagogastric variceal bleeding was seen in 34.9% (n = 30) of the H. pylori‐infected patients (n = 86) and in 59.1% (n = 65) of the noninfected patients (n = 110) (P < 0.0007). There was no significant difference in the infection rate between the bleeding sites of the esophagus and the stomach. The serum PG I and II levels and the PG I/II ratio were 65.6 ng/dL, 14.7 ng/dL, and 4.4, respectively, for the bleeding patients (n = 95), and 43.7 ng/dL, 17.7 ng/dL, and 3.1 for the nonbleeding patients (n = 101). Thus, the nonbleeding patients had significantly higher rate of H. pylori infection and lower acid secretion than bleeding patients (0.001). In addition, multivariate logistic regression analysis showed a significant negative association between H. pylori infection and esophagogastric variceal bleeding.Conclusions: These results suggest that H. pylori infection has a protective effect against esophagogastric variceal bleeding through the induction of gastric mucosal atrophy and concomitant hypoacidity.
- 1 August 2003
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 27 (Supplement) , 26S-31S
Severe Alcoholic Hepatitis Successfully Treated by Leukocytapheresis: A Case Report
- 1 August 2003
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 27 (Supplement) , 26S-31S
Severe Alcoholic Hepatitis Successfully Treated by Leukocytapheresis: A Case Report